Recent Advances in Photodynamic Therapy against Fungal Keratitis

Fungal keratitis is a serious clinical infection on the cornea caused by fungi and is one of the leading causes of blindness in Asian countries. The treatment options are currently limited to a few antifungal agents. With the increasing incidence of drug-resistant infections, many patients fail to r...

Full description

Bibliographic Details
Main Authors: Jia-Horung Hung, Chaw-Ning Lee, Huai-Wen Hsu, I-Son Ng, Chi-Jung Wu, Chun-Keung Yu, Nan-Yao Lee, Yun Chang, Tak-Wah Wong
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/12/2011
_version_ 1797501598037966848
author Jia-Horung Hung
Chaw-Ning Lee
Huai-Wen Hsu
I-Son Ng
Chi-Jung Wu
Chun-Keung Yu
Nan-Yao Lee
Yun Chang
Tak-Wah Wong
author_facet Jia-Horung Hung
Chaw-Ning Lee
Huai-Wen Hsu
I-Son Ng
Chi-Jung Wu
Chun-Keung Yu
Nan-Yao Lee
Yun Chang
Tak-Wah Wong
author_sort Jia-Horung Hung
collection DOAJ
description Fungal keratitis is a serious clinical infection on the cornea caused by fungi and is one of the leading causes of blindness in Asian countries. The treatment options are currently limited to a few antifungal agents. With the increasing incidence of drug-resistant infections, many patients fail to respond to antibiotics. Riboflavin-mediated corneal crosslinking (similar to photodynamic therapy (PDT)) for corneal ectasia was approved in the US in the early 2000s. Current evidence suggests that PDT could have the potential to inhibit fungal biofilm formation and overcome drug resistance by using riboflavin and rose bengal as photosensitizers. However, only a few clinical trials have been initiated in anti-fungal keratitis PDT treatment. Moreover, the removal of the corneal epithelium and repeated application of riboflavin and rose bengal are required to improve drug penetration before and during PDT. Thus, an improvement in trans-corneal drug delivery is mandatory for a successful and efficient treatment. In this article, we review the studies published to date using PDT against fungal keratitis and aim to enhance the understanding and awareness of this research area. The potential of modifying photosensitizers using nanotechnology to improve the efficacy of PDT on fungal keratitis is also briefly reviewed.
first_indexed 2024-03-10T03:20:45Z
format Article
id doaj.art-cd2eb44228484aa59ca3b3cb0cf017f9
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T03:20:45Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-cd2eb44228484aa59ca3b3cb0cf017f92023-11-23T10:04:41ZengMDPI AGPharmaceutics1999-49232021-11-011312201110.3390/pharmaceutics13122011Recent Advances in Photodynamic Therapy against Fungal KeratitisJia-Horung Hung0Chaw-Ning Lee1Huai-Wen Hsu2I-Son Ng3Chi-Jung Wu4Chun-Keung Yu5Nan-Yao Lee6Yun Chang7Tak-Wah Wong8Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 701, TaiwanDepartment of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, TaiwanSchool of Medicine, National Cheng Kung University, Tainan 701, TaiwanDepartment of Chemical Engineering, National Cheng Kung University, Tainan 701, TaiwanNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan 704, TaiwanInstitute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, TaiwanSchool of Medicine, National Cheng Kung University, Tainan 701, TaiwanDepartment of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, TaiwanFungal keratitis is a serious clinical infection on the cornea caused by fungi and is one of the leading causes of blindness in Asian countries. The treatment options are currently limited to a few antifungal agents. With the increasing incidence of drug-resistant infections, many patients fail to respond to antibiotics. Riboflavin-mediated corneal crosslinking (similar to photodynamic therapy (PDT)) for corneal ectasia was approved in the US in the early 2000s. Current evidence suggests that PDT could have the potential to inhibit fungal biofilm formation and overcome drug resistance by using riboflavin and rose bengal as photosensitizers. However, only a few clinical trials have been initiated in anti-fungal keratitis PDT treatment. Moreover, the removal of the corneal epithelium and repeated application of riboflavin and rose bengal are required to improve drug penetration before and during PDT. Thus, an improvement in trans-corneal drug delivery is mandatory for a successful and efficient treatment. In this article, we review the studies published to date using PDT against fungal keratitis and aim to enhance the understanding and awareness of this research area. The potential of modifying photosensitizers using nanotechnology to improve the efficacy of PDT on fungal keratitis is also briefly reviewed.https://www.mdpi.com/1999-4923/13/12/2011candidacollagen cross-linkingdrug deliveryfungal infectionflavin mononucleotidekeratitis
spellingShingle Jia-Horung Hung
Chaw-Ning Lee
Huai-Wen Hsu
I-Son Ng
Chi-Jung Wu
Chun-Keung Yu
Nan-Yao Lee
Yun Chang
Tak-Wah Wong
Recent Advances in Photodynamic Therapy against Fungal Keratitis
Pharmaceutics
candida
collagen cross-linking
drug delivery
fungal infection
flavin mononucleotide
keratitis
title Recent Advances in Photodynamic Therapy against Fungal Keratitis
title_full Recent Advances in Photodynamic Therapy against Fungal Keratitis
title_fullStr Recent Advances in Photodynamic Therapy against Fungal Keratitis
title_full_unstemmed Recent Advances in Photodynamic Therapy against Fungal Keratitis
title_short Recent Advances in Photodynamic Therapy against Fungal Keratitis
title_sort recent advances in photodynamic therapy against fungal keratitis
topic candida
collagen cross-linking
drug delivery
fungal infection
flavin mononucleotide
keratitis
url https://www.mdpi.com/1999-4923/13/12/2011
work_keys_str_mv AT jiahorunghung recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT chawninglee recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT huaiwenhsu recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT isonng recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT chijungwu recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT chunkeungyu recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT nanyaolee recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT yunchang recentadvancesinphotodynamictherapyagainstfungalkeratitis
AT takwahwong recentadvancesinphotodynamictherapyagainstfungalkeratitis